title: [What is the role of drugs in therapy of obesity?].
abstract: Drugs are part of the multimodal approach of modern obesity treatment. In the near future Sibutramine, a centrally acting serotoninergic and noradrenergic agonist and Orlistat, a peripherally acting lipase inhibitor will be available for treatment of obesity. Since all drugs employed should be applicable for years the latter substance might be especially useful for the mandatory longterm treatment of obese patients.
authors.affiliation: II. Medizinischen Klinik, Technischen Universität München, Deutschland.
authors.forename: V
authors.initials: V
authors.lastname: Schusdziarra
mesh_terms: D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D003503:Cyclobutanes / Q000009:adverse effects / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*; D000077403:Orlistat; D016896:Treatment Outcome
chemical_list: D001067:Appetite Depressants; D003503:Cyclobutanes; D004791:Enzyme Inhibitors; D007783:Lactones; D000077403:Orlistat; C058254:sibutramine